SCHEMBL26816596

SCHEMBL26816596

Cc1cccc(NC(=O)C(C)C)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.58
MDM4 O15151 2/20 0.58
CETP P11597 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
GAA P10253 1/20 0.54
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
HSD17B10 Q99714 2/20 0.53
LMNA P02545 1/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
MAPT P10636 4/20 0.53
ATM Q13315 1/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16330054 0.90 TP53 (0.63) TP53MDM4CETPL3MBTL1GAA
SCHEMBL27348492 0.86 GAA (0.51) TP53GAANPC1RAB9AHSD17B10
SCHEMBL5186841 0.85 MDM4 (0.67) TP53MDM4CETPL3MBTL1GAA
Hydrochloric Acid SCHEMBL14677158 0.84 MAPT (0.50) TP53GAANPC1RAB9AHSD17B10
SCHEMBL13255718 0.84 NPC1 (0.53) TP53GAANPC1RAB9AHSD17B10
SCHEMBL29581522 0.84 GAA (0.70) TP53GAANPC1RAB9AHSD17B10
SCHEMBL15093660 0.84 GAA (0.70) TP53GAANPC1RAB9AHSD17B10
SCHEMBL24789920 0.84 TP53 (0.56) TP53MDM4CETPL3MBTL1GAA
SCHEMBL14790209 0.84 TP53 (0.56) TP53MDM4CETPL3MBTL1GAA
SCHEMBL19214498 0.82 TP53 (0.59) TP53MDM4CETPL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators ILDONG PHARMACEUTICAL CO., LTD. (KR) 2023-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11827640-B2 Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators PDE4A, PDE4B, PDE5A TP53 3139/4885MDM4 4355/4885CETP 2532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.